RYAN WESTBROEK: Open Payments
NPI 1144608050 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 35 payments from 15 companies in 2025. Trend: 2023 $927 · 2024 $900 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $247 |
| Axsome Therapeutics, Inc. | 8 | $170 |
| Exeltis, USA Inc. | 1 | $67 |
| Abbott Laboratories | 3 | $63 |
| DePuy Synthes Sales Inc. | 1 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| SANOFI-AVENTIS U.S. LLC | 1 | $31 |
| SI-BONE, INC. | 1 | $26 |
| Ascensia Diabetes Care Us Inc. | 1 | $20 |
Products named: VRAYLAR, Sunosi, TWIRLA, FREESTYLE LIBRE 3, Symbravo, MOTOBAND, VOQUEZNA, CAPLYTA.
Industry payments across UT — which companies pay providers there.
